2025-08-05T01:11:55.693797+0800 INFO SYS-Warmup function started
2025-08-05T01:11:55.693963+0800 INFO CONFIG-Config path: configs/openai.json
2025-08-05T01:11:55.694050+0800 INFO CONFIG-Config: {'chat_config': {'chat_model': 'Qwen/Qwen3-8B', 'chat_model_type': 'instruction', 'chat_model_inference_engine': 'openai', 'chat_system_message': 'You are a helpful assistant.', 'chat_parameters': {'temperature': 0.6}, 'chat_max_new_token': 1000, 'chat_request_timeout': 1000}, 'emb_config': {'emb_model_name': 'text-embedding-3-large', 'request_endpoint': 'https://api.openai.com/v1/embeddings', 'emb_size': 3072, 'embedding_timeout': 600}, 'env_config': {'trading_symbols': ['UVV', 'JNJ'], 'warmup_start_time': '2020-07-02', 'warmup_end_time': '2020-09-30', 'test_start_time': '2020-10-01', 'test_end_time': '2021-05-06', 'momentum_window_size': 3, 'env_data_path': {'UVV': 'data/uvv.json', 'JNJ': 'data/jnj.json'}}, 'portfolio_config': {'trading_symbols': ['UVV', 'JNJ'], 'type': 'multi-assets', 'cash': 100000000000, 'look_back_window_size': 3}, 'agent_config': {'agent_name': 'agent', 'trading_symbols': ['UVV', 'JNJ'], 'character_string': {'UVV': "You accumulate a lot of information about Universal Corporation (UVV) in the following sectors so you are especially good at trading them: (1)Tobacco: This is the core sector for Universal Corporation, where they engage in the processing, procurement, and supply of leaf tobaccos. This includes various types of tobacco such as flue-cured, burley, and dark air-cured used in cigarettes and other tobacco products. (2) Ingredients: Universal Corporation has expanded into the plant-based ingredients sector. This involves producing and supplying plant-based ingredients derived from various agricultural products for food and beverage companies.You are an investment expert of Universal Corporation (UVV). You learned the following knowledge about Universal Corporation (UVV) based on your professional experience. Universal Corporation (UVV), a leading global leaf tobacco supplier, exhibited stable financial performance in 2019, with total revenues reaching $2.2 billion, consistent with the previous year's figures. The company's profitability in 2019 was robust, driven by strong global demand for tobacco products and operational efficiencies. However, the stock trended relatively flat throughout 2019, reflecting the mature nature of the tobacco market and ongoing global regulatory pressures. The year 2020 brought additional challenges, particularly due to the COVID-19 pandemic, which impacted the global supply chain and reduced demand in certain markets. Despite these hurdles, Universal Corporation managed to maintain operational continuity, although its revenue streams faced pressure in various geographic segments. By the end of the third quarter of 2020, UVV's stock had experienced volatility but showed signs of recovery as the company adapted to new market conditions and continued to leverage its strong position in the leaf tobacco sector. At the beginning of the fourth quarter of 2020, professional analysts were cautiously optimistic about Universal Corporation (UVV) for the remainder of the year and into 2021. For 2021, analysts expected a steady demand for UVV's products, particularly in emerging markets, and saw potential growth opportunities in the company's recent ventures into non-tobacco agricultural products, which could offset some of the declines in traditional tobacco sales.", 'JNJ': "You accumulate a lot of information about Johnson & Johnson (JNJ) in the following sectors so you are especially good at trading them: (1) Pharmaceuticals Sector: This is the largest segment of Johnson & Johnson, involving the research, development, and sale of pharmaceutical products across various therapeutic areas such as immunology, oncology, neurology, and infectious diseases. (2) Medical Devices Sector: JNJ is a significant player in the medical devices sector, providing a wide range of products used in orthopedics, surgery, cardiovascular, diabetes care, and other fields. (3) Consumer Health Sector: This sector includes a broad array of over-the-counter (OTC) products, skin care products, and baby care products, among other consumer health items. You are an investment expert of Johnson & Johnson (JNJ). You learned the following knowledge about Johnson & Johnson (JNJ) based on your professional experience. Johnson & Johnson (JNJ) demonstrated robust financial performance in 2019, generating revenues of $82.1 billion, up 0.6% from the previous year, driven by strong sales in its pharmaceuticals and medical devices segments. The company's net earnings for the year stood at $15.1 billion, reflecting a solid operational performance and strategic management of its diversified healthcare portfolio. JNJ's stock performed well in 2019, buoyed by consistent earnings growth and a reputation for stability in the healthcare sector. In 2020, JNJ faced unprecedented challenges due to the COVID-19 pandemic, impacting its medical devices segment due to reduced elective surgeries. However, its pharmaceuticals and consumer health divisions saw increased demand, particularly for products related to immune health and hygiene. By the end of the third quarter of 2020, JNJ's stock had shown resilience, recovering from a dip in March, driven by positive news regarding its progress on a COVID-19 vaccine candidate and stable financial performance despite global economic uncertainties. At the beginning of the fourth quarter of 2020, professional analysts were optimistic about Johnson & Johnson (JNJ) for the rest of the year and into 2021. They expected continued resilience in JNJ's pharmaceutical and consumer health segments, which could offset challenges faced by the medical devices division due to the pandemic. For 2021, analysts were particularly positive about the potential approval and distribution of JNJ's COVID-19 vaccine, which could significantly boost the company's profile and financial performance, alongside a recovery in elective medical procedures as global conditions improve."}, 'top_k': 5, 'memory_db_config': {'memory_db_endpoint': 'http://localhost:6333', 'memory_importance_upper_bound': 100.0, 'memory_importance_score_update_step': 18.0, 'trading_symbols': ['UVV', 'JNJ'], 'short': {'db_name': 'short', 'importance_init_val': 50.0, 'decay_recency_factor': 3.0, 'decay_importance_factor': 0.92, 'clean_up_recency_threshold': 0.05, 'clean_up_importance_threshold': 5.0, 'jump_upper_threshold': 55.0}, 'mid': {'db_name': 'mid', 'importance_init_val': 60.0, 'decay_recency_factor': 90.0, 'decay_importance_factor': 0.96, 'clean_up_recency_threshold': 0.05, 'clean_up_importance_threshold': 5.0, 'jump_lower_threshold': 55.0, 'jump_upper_threshold': 85.0}, 'long': {'db_name': 'long', 'importance_init_val': 90.0, 'decay_recency_factor': 365.0, 'decay_importance_factor': 0.96, 'clean_up_recency_threshold': 0.05, 'clean_up_importance_threshold': 5.0, 'jump_lower_threshold': 85.0}, 'reflection': {'db_name': 'reflection', 'importance_init_val': 80.0, 'decay_recency_factor': 365.0, 'decay_importance_factor': 0.98, 'clean_up_recency_threshold': 0.05, 'clean_up_importance_threshold': 5.0, 'similarity_threshold': 0.95}}}, 'meta_config': {'run_name': 'exp', 'momentum_window_size': 3, 'warmup_checkpoint_save_path': 'results/exp/gpt-4-turbo/UVV_TSLA_JNJ/warmup_checkpoint', 'warmup_output_save_path': 'results/exp/gpt-4-turbo/UVV_TSLA_JNJ/warmup_output', 'test_checkpoint_save_path': 'results/exp/gpt-4-turbo/UVV_TSLA_JNJ/test_checkpoint', 'test_output_save_path': 'results/exp/gpt-4-turbo/UVV_TSLA_JNJ/test_output', 'result_save_path': 'results/exp/gpt-4-turbo/UVV_TSLA_JNJ/final_result', 'log_save_path': 'results/exp/gpt-4-turbo/UVV_TSLA_JNJ/log'}}
2025-08-05T01:11:55.694265+0800 INFO ENV-Creating MarketEnvironment with params: env_data_pkl {'UVV': 'data/uvv.json', 'JNJ': 'data/jnj.json'}, start_date 2020-07-02, end_date 2020-09-30, symbol ['UVV', 'JNJ']
2025-08-05T01:11:55.699219+0800 INFO ENV-Final date series (intersection): [datetime.date(2020, 7, 2), datetime.date(2020, 7, 6), datetime.date(2020, 7, 7), datetime.date(2020, 7, 8), datetime.date(2020, 7, 9), datetime.date(2020, 7, 10), datetime.date(2020, 7, 13), datetime.date(2020, 7, 14), datetime.date(2020, 7, 15), datetime.date(2020, 7, 16), datetime.date(2020, 7, 17), datetime.date(2020, 7, 20), datetime.date(2020, 7, 21), datetime.date(2020, 7, 22), datetime.date(2020, 7, 23), datetime.date(2020, 7, 24), datetime.date(2020, 7, 27), datetime.date(2020, 7, 28), datetime.date(2020, 7, 29), datetime.date(2020, 7, 30), datetime.date(2020, 7, 31), datetime.date(2020, 8, 3), datetime.date(2020, 8, 4), datetime.date(2020, 8, 5), datetime.date(2020, 8, 6), datetime.date(2020, 8, 7), datetime.date(2020, 8, 10), datetime.date(2020, 8, 11), datetime.date(2020, 8, 12), datetime.date(2020, 8, 13), datetime.date(2020, 8, 14), datetime.date(2020, 8, 17), datetime.date(2020, 8, 18), datetime.date(2020, 8, 19), datetime.date(2020, 8, 20), datetime.date(2020, 8, 21), datetime.date(2020, 8, 24), datetime.date(2020, 8, 25), datetime.date(2020, 8, 26), datetime.date(2020, 8, 27), datetime.date(2020, 8, 28), datetime.date(2020, 8, 31), datetime.date(2020, 9, 1), datetime.date(2020, 9, 2), datetime.date(2020, 9, 3), datetime.date(2020, 9, 4), datetime.date(2020, 9, 8), datetime.date(2020, 9, 9), datetime.date(2020, 9, 10), datetime.date(2020, 9, 11), datetime.date(2020, 9, 14), datetime.date(2020, 9, 15), datetime.date(2020, 9, 16), datetime.date(2020, 9, 17), datetime.date(2020, 9, 18), datetime.date(2020, 9, 21), datetime.date(2020, 9, 22), datetime.date(2020, 9, 23), datetime.date(2020, 9, 24), datetime.date(2020, 9, 25), datetime.date(2020, 9, 28), datetime.date(2020, 9, 29), datetime.date(2020, 9, 30)]
2025-08-05T01:11:55.699364+0800 INFO ENV-Simulation-Length: 63
2025-08-05T01:11:55.699425+0800 INFO SYS-Initializing FinMemAgent
2025-08-05T01:11:55.699736+0800 INFO SYS-Initializing MemoryDB
2025-08-05T01:11:55.801468+0800 ERROR SYS-Multi-asset not implemented for OpenAI
